Author(s): Michael M. Boyiadzis
This is the first clinical manual to bridge the disciplines of hematology and oncology. "Hematology-Oncology Therapy" is a readily-accessible, up-to-date therapy guide for oncologic and non-neoplastic hematologic disorders. This comprehensive book presents 500 treatment regimens in a concise, uniform format and integrates critical treatment information from the oncology and hematology literature, practice guidelines, and the experience of experts. The new edition is thoroughly updated with new content, drug regimens, and authors. It is completely updated to reflect new classes of cancer drugs, including targeted biologicals. It features new 9 additional international contributors. It includes new chapters such as: Pregnancy and Chemotherapy; Hematologic Complications of Pregnancy; and, Hemochromatosis. It features: new 'Expert Opinion' added to every Oncology chapter; and, new Drug Index. It is more comprehensive than any other manual on the market. It includes thoroughly updated content: Section I - Oncology; Section II - Supportive Care, Drug Preparation, Complications, and Screening; and, Section III - Selected Hematologic Diseases.
About the Authors Michael M. Boyiadzis, MD, MHSc Assistant Professor of Medicine, Division of Hematology-Oncology, University of Pittsburgh Cancer Institute, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania Tito Fojo, MD, PhD Senior Principal Investigator, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Peter F. Lebowitz, MD, PhD Assistant Professor of Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC James N. Frame, MD Clinical Associate Professor, Robert C. Byrd Health Sciences Center of West Virginia University School of Medicine, Charleston Division, Charleston, West Virginia David R. Kohler, PharmD Oncology Clinical Pharmacy Specialist, National Institutes of Health Clinical Center, Bethesda, Maryland Global Contributors Salah Y. Abbasi, MD Assistant Professor, Department of Internal Medicine, Jordan University of Science and Technology; Kind Abdullah University Hospital, Irbid, Jordan Jordi Bruix, MD BCLC Group, Liver Unit, Hospital Clinic, University of Barcelona; IDIBAPS, Barcelona, Spain Enriqueta Felip, MD, PhD Medical Oncology Department; Vall d'Hebron University Hospital, Barcelona, Spain Giuseppe Giaccone, MD Professor, VU University Medical Center, Department of Medical Oncology, Amsterdam, The Netherlands Eva Tiensuu Janson, MD Associate Professor, Department of Medical Sciences, Uppsala University Hospital; Senior Consultant, Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden Gregory D. Leonard, MD Consultant Medical Ongologist, Old School of Nursing, Dunmore Rono, Watorford Regional Hospital, Waterford, Ireland Joan Maurel, MD BCLC group. Hospital Clinic Barcelona, Medical Oncology Department; University of Barcelona, Barcelona, Spain Kjell Oberg, MD Professors, Endocrine Oncology, Dean of the Medical Faculty, Uppsala University; Professor, Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden Rafael Rosell, MD Associate Professor, School of Medicine, Autonomous University of Barcelona; Catalan Institute of Oncology, Hospital Germans Trias, Pujol, Badalona, Barcelona, Spain Verena Sagaster, MD Department of Internal Medicine I, Division of Oncology, Vienna University Medical School; Vienna University Hospital, Vienna, Austria Werner Scheithauer, MD Department of Internal Medicine I, Division of Oncology, Vienna University Medical School; Vienna University Hospital, Vienna, Austria Hanneke Wilmink, MD Academic Medical Center Amsterdam, Department of Medical Oncology, Amsterdam, The Netherlands
Section I: Oncology Section II: Supportive Care, Drug Preparation, Complications, and Screening Section III: Selected Hematologic Diseases